Skip to main content

Month: July 2022

GasLog Ltd. Announces Availability of 2021 Sustainability Report

Hamilton, Bermuda, July 14, 2022 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or the “Company”) (NYSE: GLOG PRA) today announced the availability of the Company’s 2021 Sustainability Report.  The Sustainability Report, which can be accessed on the Company’s website, has been compiled in general compliance with the Sustainability Accounting Standards Board (“SASB”) Marine Transportation standard.  In the Report, GasLog summarizes progress delivered around the focus areas of decarbonization, safety and wellbeing, and diversity, equity and inclusion, among other areas. GasLog 2021 Sustainability Report: www.gaslogltd.com/investors/sustainability/ Contacts: Alex PapadimitriouEmail: ir@gaslogltd.com About GasLog GasLog is an international owner, operator and manager of LNG carriers providing support to international energy companies as...

Continue reading

Leading Edge Materials Receives Approval for First-Year Exploration Program in Romania

20220714 Bihor Sud exploration map Map of the exploration license in Bihor SudVancouver, July 14, 2022 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) is pleased to report that it has received confirmation that the National Agency for Mineral Resources (“NAMR”) has approved the first-year exploration program (the “Exploration Program”) for the Bihor Sud exploration license (the “Project”). Highlights:Exploration to focus on surface mapping and re-opening historical galleries Rock grab samples from mine dumps report grades up to 6.8% Cobalt and 28% NickelThe Exploration Program covers a number of initial exploration activities to validate the geological potential of the Project and further build on information acquired under the earlier prospecting...

Continue reading

DMC Global Schedules Second Quarter Earnings Release and Conference Call 2022

BROOMFIELD, Colo., July 14, 2022 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) will announce its 2022 second quarter financial results after the stock market closes on Thursday, August 4, 2022.  Following the earnings release, executive management will host a conference call and simultaneous webcast. The conference call will begin at 5 p.m. Eastern (3 p.m. Mountain) and will be accessible by dialing 888-506-0062 (973-528-0011 for international callers) and entering the code 762205. A telephonic replay will be available through August 11, 2022, by calling 877-481-4010 (919-882-2331 for international callers) and entering the Conference ID #46132. Investors are invited to listen to the webcast live via the Internet at: https://www.webcaster4.com/Webcast/Page/2204/46132 The webcast also will be available on the Investor page...

Continue reading

SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U.S. markets open on Tuesday, August 9, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. EDT / 2:30 p.m. CEST. The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion. About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform,...

Continue reading

American Lithium intersects up to 2,900 ppm Li in best results to date from thick lithium claystone averaging 1,550 ppm Li over 50.3 m in hole TLC-2206C

Figure 1 TLC Project Drill Hole Location MapVANCOUVER, British Columbia, July 14, 2022 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | OTCQB:LIACF | Frankfurt:5LA1) is pleased to provide an update of initial diamond drill results from the program currently underway at the Tonopah Lithium Claims (“TLC”) project located northwest of Tonopah, Nevada. This diamond drill program is focused on expanding the existing large-scale near surface TLC resource. An update on Reverse Circulation (“RC”) drill program results to date is expected to be released in the coming weeks. Resource Expansion and In-fill Core Drilling:Link to: Figure 1 – TLC Project Drill Hole Location Map (also see below)Large drill program launched in February 2022 under Plan of Operations finalized in January 2022. Large...

Continue reading

HydroGraph Launches Patented Graphene Ink

HydroGraph is Now Producing Graphene at Volume TORONTO, July 14, 2022 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (HG.CN) (the “Company” or “HydroGraph”), a commercial manufacturer of high-quality nanomaterials and alternative-energy fuels, has launched its patented graphene ink, an entirely new and novel form of “conductive ink” that maintains the valuable qualities of graphene including strength, non-toxicity, flexibility, and optical transparency. As the name suggests, conductive ink is a material that conducts energy with the utility of an ink. This development marks a significant step toward the production of inexpensive, foldable, and wearable electronics. “This is a significant milestone in renewable technology production. From touch screen displays, biosensors, radio frequency identification tags, electric vehicle batteries,...

Continue reading

Roche, Merck & Co, and Bayer Among Leading Companies in the Glioblastoma Multiforme Market | GlobalData Plc

The US is expected to retain its position as the largest market for glioblastoma multiforme in 2030 LONDON, July 14, 2022 (GLOBE NEWSWIRE) — The “Glioblastoma Multiforme: Global Drug Forecast and Market Analysis to 2030” report offered by GlobalData provide opportunities for various marketed agents and pipeline agents in development across the 8MM, clinical and commercial assessments for agents in late-stage clinical development, R&D strategies, and innovative approaches in development for glioblastoma multiforme. The total sales of glioblastoma multiforme (GBM) therapies was estimated to be $549.1 million in 2020 across the 8MM and is expected to increase at a CAGR of more than 4% by 2030. The market growth will be driven by the anticipated launch of eight pipeline agents, of which cancer vaccines and protein kinase inhibitors...

Continue reading

TOWER ONE WIRELESS ANNOUNCES TWENTY-TWO TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 2,600,000

TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF JUNE 2022 VANCOUVER, BC, CANADA, July 14, 2022 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) is pleased to provide a construction update for the month of June 2022. During the month of June, the Company completed twenty-two (22) new towers: eleven (11) towers in Colombia, ten (10) towers in Ecuador, and one (1) tower in Mexico with a total of fifty-one (51) towers under construction in these specific countries, as well. These towers are built to suit for specific clients and will provide a total, non-cancellable rent revenue for 10 years of approximately $2,600,000 (*This figure excludes colocation revenue upside and inflation escalator terms). Tower One began the year with 204 towers in operation and as of June...

Continue reading

Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires

Jack Gold Chief Marketing OfficerDenise Dettore Chief People OfficerVANCOUVER, Wash. and NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced two senior executive hires in newly created roles as it prepares for its next stage of growth. Denise Dettore joins as Chief People Officer and Jack Gold becomes Chief Marketing Officer.  Dettore joins Absci with 26 years of experience in Human Resources in Silicon Valley, 10 years of which were in high-tech companies including Hewlett-Packard and Electronic Arts. For the past 16 years she has been working in the biotech industry, spending time at Genentech, Jazz Pharmaceuticals and BeiGene. At BeiGene, Dettore...

Continue reading

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene®•GUT DNA and RNA product (OMR-205) is now available to gut microbiome researchers. The product allows for self-collection, stabilization, storage and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling. It is made by OraSure’s subsidiary DNA Genotek. “This product gives researchers in the pharmaceutical, biotechnical, academic, and consumer products fields a valuable tool to gain insight into the gene expression of gut microbes,” said Kathleen Weber, President of Molecular Solutions for OraSure Technologies. “It also aligns with our multiomics strategy and the recent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.